BR9915095A - Composição farmacêutica ministrável em aerosol - Google Patents
Composição farmacêutica ministrável em aerosolInfo
- Publication number
- BR9915095A BR9915095A BR9915095-6A BR9915095A BR9915095A BR 9915095 A BR9915095 A BR 9915095A BR 9915095 A BR9915095 A BR 9915095A BR 9915095 A BR9915095 A BR 9915095A
- Authority
- BR
- Brazil
- Prior art keywords
- delta
- aerosol
- thc
- pharmaceutical composition
- composition administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA ADMINISTRáVEL EM AEROSSOL". A presente invenção se refere a formulações terapêuticas para soluções de <30>^ 9^-tetraidrocanabinol (<30>^ 9^-THC) para serem disseminadas através de inaladores de dose quantificada. As formulações que não utilizam propelentes que não CFC oferecem uma fonte de <30>^ 9^-THC que pode ser disseminada através de aerossol, para o tratamento de diferentes condições médicas, tais como: náusea e vómito associados com quimioterapia; espasticidade muscular; dor; anorexia associada com a perda excessiva de peso devido à AIDS; epilepsia; glaucoma; asma brónquica; e distúrbios de condições psicológicas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10585098P | 1998-10-27 | 1998-10-27 | |
US09/273,766 US6509005B1 (en) | 1998-10-27 | 1999-03-22 | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
PCT/US1999/024486 WO2000024362A2 (en) | 1998-10-27 | 1999-10-20 | Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915095A true BR9915095A (pt) | 2002-01-15 |
Family
ID=26803013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915095-6A BR9915095A (pt) | 1998-10-27 | 1999-10-20 | Composição farmacêutica ministrável em aerosol |
Country Status (14)
Country | Link |
---|---|
US (3) | US6509005B1 (pt) |
EP (1) | EP1124551B1 (pt) |
JP (1) | JP2002528399A (pt) |
KR (1) | KR100636854B1 (pt) |
CN (1) | CN1214789C (pt) |
AT (1) | ATE391501T1 (pt) |
AU (1) | AU764119B2 (pt) |
BR (1) | BR9915095A (pt) |
CA (1) | CA2344637A1 (pt) |
DE (1) | DE69938505T2 (pt) |
ES (1) | ES2308855T3 (pt) |
HK (1) | HK1042846B (pt) |
MX (1) | MXPA01004188A (pt) |
WO (1) | WO2000024362A2 (pt) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ517517A (en) * | 1999-08-20 | 2004-03-26 | Unimed Pharmaceuticals Inc | Composition for inhalation comprising delta-9- tetrahydrocannabinol in a semiaqueous solvent |
US6747058B1 (en) | 1999-08-20 | 2004-06-08 | Unimed Pharmaceuticals, Inc. | Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
US7648696B2 (en) * | 1999-08-20 | 2010-01-19 | Unimed Pharmaceuticals, Llc | Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
WO2001064212A1 (en) * | 2000-03-01 | 2001-09-07 | University College London | Modulators of the endocannabinoid uptake and of the vallinoid receptors |
GB2361869B (en) * | 2000-03-09 | 2004-09-22 | Pharmasol Ltd | Sublingual delivery of cannabis |
AU782991B2 (en) | 2000-03-09 | 2005-09-15 | GW Research Limited | Pharmaceutical compositions |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
GB0025092D0 (en) * | 2000-10-13 | 2000-11-29 | Glaxo Group Ltd | Medicament dispenser |
US10004684B2 (en) | 2001-02-14 | 2018-06-26 | Gw Pharma Limited | Pharmaceutical formulations |
US7905230B2 (en) | 2001-05-09 | 2011-03-15 | Novartis Ag | Metered dose inhaler with lockout |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
JP2005503425A (ja) * | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | 所定の吸入ルートによる薬剤エステルの送出 |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
WO2003006010A1 (en) * | 2001-07-10 | 2003-01-23 | Norton Healthcare Limited | Aerosol formulations of δ8 tetrahydrocannabinol |
WO2003051367A1 (en) * | 2001-12-18 | 2003-06-26 | Alexza Molecular Delivery Corporation | Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist |
EP1321159A1 (en) | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices |
US6900317B2 (en) * | 2002-02-19 | 2005-05-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them |
DE10206770A1 (de) * | 2002-02-19 | 2003-08-28 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Pulverinhalativums enthaltend ein Salz des CGRP-Antagonisten BIBN4096 |
IL148244A0 (en) * | 2002-02-19 | 2002-09-12 | Yissum Res Dev Co | Anti-nausea and anti-vomiting activity of cannabidiol compounds |
US20040014679A1 (en) * | 2002-02-20 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof |
ATE413862T1 (de) * | 2002-04-03 | 2008-11-15 | Solvay Pharm Bv | Stabilisierte natürliche cannabinoid formulierung |
US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
US20080159961A1 (en) * | 2002-06-22 | 2008-07-03 | Austen John Woolfe | Pharmaceutical Composition |
US10538373B2 (en) | 2002-08-14 | 2020-01-21 | Gw Pharma Limited | Pharmaceutical formulation |
US6946150B2 (en) | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
CA2526478A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same |
WO2005044093A2 (en) * | 2003-11-05 | 2005-05-19 | Unimed Pharmaceuticals, Inc. | Delta-9- the treatment of multiple sclerosis |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
TWI369203B (en) * | 2004-11-22 | 2012-08-01 | Euro Celtique Sa | Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol |
EA200701246A1 (ru) * | 2004-12-09 | 2008-06-30 | Инсис Терапьютикс, Инк. | Стабильные при комнатной температуре составы дронабинола |
EP1855666A1 (en) * | 2005-02-25 | 2007-11-21 | Unimed Pharmaceuticals, Inc. | Dronabinol compositions and methods of using same |
US20070072938A1 (en) * | 2005-05-13 | 2007-03-29 | Kevin Rose | Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting |
ES2357250T3 (es) * | 2005-06-16 | 2011-04-20 | Euro-Celtique S.A. | Composiciones que comprenden trans-(+/-)-delta-9-tetrahidrocannabinol cristalino. |
TWI366460B (en) | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
EP1898877A1 (en) * | 2005-06-20 | 2008-03-19 | Unimed Pharmaceuticals, Inc. | Dronabinol treatment for migraines |
EP2046290A4 (en) * | 2006-08-04 | 2011-08-17 | Insys Therapeutics Inc | AQUEOUS DRONABINOL FORMULATIONS |
GB0702895D0 (en) * | 2007-02-14 | 2007-03-28 | Resolution Chemicals Ltd | Delta 9 tetrahydrocannabinol derivatives |
GB0703284D0 (en) * | 2007-02-20 | 2007-03-28 | Resolution Chemicals Ltd | Delta 9 - tetrahydrocannabinol processing |
JP2008212436A (ja) | 2007-03-06 | 2008-09-18 | Canon Inc | 吸入装置 |
EP2121088B1 (en) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
US8222292B2 (en) | 2007-08-06 | 2012-07-17 | Insys Therapeutics, Inc. | Liquid cannabinoid formulations |
US20090181080A1 (en) * | 2007-08-06 | 2009-07-16 | Insys Therapeutics Inc. | Oral cannabinnoid liquid formulations and methods of treatment |
JP2009106467A (ja) | 2007-10-30 | 2009-05-21 | Canon Inc | 吸入装置 |
US20110038915A1 (en) * | 2009-08-14 | 2011-02-17 | Eduardo Jose Gonzalez | Chewing Gum Formula for Enhancing Psycho-Spirituality |
WO2012006126A1 (en) * | 2010-06-28 | 2012-01-12 | Palliatech | Cannabis drug delivery and monitoring system |
US8910630B2 (en) | 2010-06-28 | 2014-12-16 | Palliatech, Inc. | Cannabis drug delivery and monitoring system |
CA2822738C (en) | 2010-12-22 | 2021-06-08 | Exonoid Medical Devices Ltd. | Method and system for drug delivery |
US10265293B2 (en) | 2012-10-04 | 2019-04-23 | Insys Development Company, Inc. | Oral cannabinoid formulations |
US9345771B2 (en) | 2012-10-04 | 2016-05-24 | Insys Development Company, Inc. | Oral cannabinoid formulations |
US11253472B2 (en) | 2012-10-04 | 2022-02-22 | Benuvia Therapeutics Llc | Oral cannabinoid formulations |
WO2015195711A2 (en) * | 2014-06-16 | 2015-12-23 | Shurtleff, James, Kevin | Method and devices for manufacturing and delivering of aerosolized formulations |
WO2015200049A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
EP3160552B1 (en) | 2014-06-30 | 2019-05-08 | Syqe Medical Ltd. | Drug dose cartridge for an inhaler device |
WO2016001922A1 (en) | 2014-06-30 | 2016-01-07 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
EP3160565B1 (en) | 2014-06-30 | 2021-08-18 | Syqe Medical Ltd. | Devices and systems for pulmonary delivery of active agents |
EP3160553B1 (en) | 2014-06-30 | 2021-10-20 | Syqe Medical Ltd. | Device for vaporization and inhalation of isolated substances |
BR112016030955B1 (pt) | 2014-06-30 | 2022-03-22 | Syqe Medical Ltd. | Dispositivo inalador |
US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
US9844518B2 (en) | 2014-09-30 | 2017-12-19 | MJAR Holdings, LLC | Methods of growing cannabaceae plants using artificial lighting |
EP3215148B1 (en) | 2014-11-03 | 2022-04-13 | Ramot at Tel-Aviv University Ltd. | Use of low dose of tetrahydrocannabinol for the treatment of cognitive decline in elderly patients |
AU2016263444B2 (en) * | 2015-05-21 | 2019-03-07 | Island Breeze Systems Ca, Llc | Propellant based metered dose inhaler and food applicators and applicators |
US20170038184A1 (en) * | 2015-08-06 | 2017-02-09 | Charles E. Ankner | Formulation delivery system |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
US11806331B2 (en) | 2016-01-06 | 2023-11-07 | Syqe Medical Ltd. | Low dose therapeutic treatment |
DK3474844T3 (da) | 2016-06-28 | 2022-08-29 | Trichomeshell Ltd | Doseringsform til fordampning og rygning |
US9717683B1 (en) | 2016-06-29 | 2017-08-01 | Ep Pharma, Llc | Low-temperature inhalation administration of cannabinoid entities |
US10231948B2 (en) | 2017-02-27 | 2019-03-19 | Jason Ty Nguyen | Metered dose inhaler compositions, systems, and methods |
US11786463B2 (en) | 2017-08-27 | 2023-10-17 | Rhodes Technologies | Pharmaceutical compositions for the treatment of ophthalmic conditions |
GB2567240B (en) | 2017-10-09 | 2022-04-06 | Senzer Ltd | An inhaler particularly a cannabinoid inhaler and a method of assembling such an inhaler |
WO2020016658A2 (en) | 2018-07-18 | 2020-01-23 | Glatt Gmbh | Immediate release formulations of cannabinoids |
CA3115116A1 (en) * | 2018-10-01 | 2020-04-09 | Blue Harvest, Llc | Ultrapure phenol compositions |
US11806645B1 (en) | 2019-05-07 | 2023-11-07 | Cannaceutical Extractions LLC | Methods of producing CBD/THC oils |
CN110200953B (zh) * | 2019-06-15 | 2022-02-08 | 汉义生物科技(北京)有限公司 | ***素在制备吸入给药药物中的应用 |
US20230117531A1 (en) * | 2020-03-19 | 2023-04-20 | Tff Pharmaceuticals, Inc. | Dried particle inhalation for delivery of cannabis |
US11542226B2 (en) * | 2020-04-23 | 2023-01-03 | Axim Biotechnologies, Inc. | Polyfunctional cannabinoids |
EP3919046A1 (en) | 2020-06-02 | 2021-12-08 | Athenion AG | Method for solubilizing natural, endogenous and synthetic cannabinoids |
GB2595692A (en) | 2020-06-03 | 2021-12-08 | Senzer Ltd | A refill for an inhaler particularly a cannabinoid inhaler |
EP4167981A1 (en) * | 2020-06-22 | 2023-04-26 | Jupiter Wellness, Inc. | Oronasal cannabinoid formulations and uses thereof |
WO2022115718A1 (en) * | 2020-11-29 | 2022-06-02 | Castor Trevor P | Extraction, separation and purification of cannabinoids from cannabis staiva and other marijuana biomass |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3728360A (en) * | 1971-08-31 | 1973-04-17 | Little Inc A | Ester derivatives of tetrahydrocannabinol |
US4087547A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones in treatment of glaucoma |
US4087546A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs |
US4635651A (en) * | 1980-08-29 | 1987-01-13 | Jacobs Allen W | Process for the inclusion of a solid particulate component into aerosol formulations of inhalable nicotine |
US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
US4476140A (en) * | 1983-05-16 | 1984-10-09 | Yale University | Composition and method for treatment of glaucoma |
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US4847290A (en) * | 1987-08-17 | 1989-07-11 | Sumner Burstein | Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents |
US5538993A (en) * | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
US5916540A (en) * | 1994-10-24 | 1999-06-29 | Glaxo Group Limited | Aerosol formulations containing P134A and/or P227 and particulate medicament |
AU663905B2 (en) * | 1991-12-12 | 1995-10-26 | Glaxo Group Limited | Medicaments |
US5653962A (en) * | 1991-12-12 | 1997-08-05 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
US5284133A (en) * | 1992-07-23 | 1994-02-08 | Armstrong Pharmaceuticals, Inc. | Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means |
US5492688A (en) * | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
AU680967B2 (en) * | 1993-12-20 | 1997-08-14 | Minnesota Mining And Manufacturing Company | Flunisolide aerosol formulations |
US5502076A (en) * | 1994-03-08 | 1996-03-26 | Hoffmann-La Roche Inc. | Dispersing agents for use with hydrofluoroalkane propellants |
US5653961A (en) * | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
US6017963A (en) * | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
ATE244708T1 (de) * | 1996-05-14 | 2003-07-15 | Glaxo Group Ltd | Benzofurane und benzpyrane als chronobiologische mittel |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
NZ336049A (en) * | 1996-12-04 | 2000-09-29 | Bioglan Ireland R & D Ltd | Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container |
JP2001507701A (ja) * | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティック・システムズ・インコーポレーテッド | 親水性賦形剤を有する疎水性薬剤の溶液を噴霧乾燥するための方法及びその方法によって作製された組成物 |
US5804592A (en) * | 1997-05-30 | 1998-09-08 | Unimed Pharmaceuticals, Inc. | Method for improving disturbed behavior and elevating mood in humans |
US7025992B2 (en) * | 2001-02-14 | 2006-04-11 | Gw Pharma Limited | Pharmaceutical formulations |
-
1999
- 1999-03-22 US US09/273,766 patent/US6509005B1/en not_active Expired - Lifetime
- 1999-10-20 CN CN99812654.3A patent/CN1214789C/zh not_active Expired - Fee Related
- 1999-10-20 AT AT99965726T patent/ATE391501T1/de not_active IP Right Cessation
- 1999-10-20 ES ES99965726T patent/ES2308855T3/es not_active Expired - Lifetime
- 1999-10-20 KR KR1020017004513A patent/KR100636854B1/ko not_active IP Right Cessation
- 1999-10-20 AU AU21430/00A patent/AU764119B2/en not_active Ceased
- 1999-10-20 EP EP99965726A patent/EP1124551B1/en not_active Expired - Lifetime
- 1999-10-20 WO PCT/US1999/024486 patent/WO2000024362A2/en active IP Right Grant
- 1999-10-20 JP JP2000577974A patent/JP2002528399A/ja active Pending
- 1999-10-20 MX MXPA01004188A patent/MXPA01004188A/es not_active IP Right Cessation
- 1999-10-20 BR BR9915095-6A patent/BR9915095A/pt not_active Application Discontinuation
- 1999-10-20 CA CA002344637A patent/CA2344637A1/en not_active Abandoned
- 1999-10-20 DE DE69938505T patent/DE69938505T2/de not_active Expired - Fee Related
-
2001
- 2001-09-04 US US09/944,221 patent/US6713048B2/en not_active Expired - Lifetime
-
2002
- 2002-05-28 HK HK02103979.7A patent/HK1042846B/zh not_active IP Right Cessation
-
2004
- 2004-01-20 US US10/759,280 patent/US20040258622A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2344637A1 (en) | 2000-05-04 |
EP1124551A4 (en) | 2004-10-13 |
AU2143000A (en) | 2000-05-15 |
KR20010075610A (ko) | 2001-08-09 |
DE69938505D1 (de) | 2008-05-21 |
US6713048B2 (en) | 2004-03-30 |
EP1124551A2 (en) | 2001-08-22 |
ATE391501T1 (de) | 2008-04-15 |
DE69938505T2 (de) | 2009-07-09 |
KR100636854B1 (ko) | 2006-10-20 |
EP1124551B1 (en) | 2008-04-09 |
HK1042846B (zh) | 2006-01-20 |
ES2308855T3 (es) | 2008-12-01 |
HK1042846A1 (en) | 2002-08-30 |
WO2000024362A2 (en) | 2000-05-04 |
JP2002528399A (ja) | 2002-09-03 |
US20040258622A1 (en) | 2004-12-23 |
US20020031480A1 (en) | 2002-03-14 |
US6509005B1 (en) | 2003-01-21 |
WO2000024362A3 (en) | 2000-08-24 |
MXPA01004188A (es) | 2002-06-04 |
CN1324236A (zh) | 2001-11-28 |
CN1214789C (zh) | 2005-08-17 |
AU764119B2 (en) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9915095A (pt) | Composição farmacêutica ministrável em aerosol | |
IT1317846B1 (it) | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. | |
NZ534040A (en) | Metered dose inhaler | |
SG157406A1 (en) | Oral medicament for the modified release of at least one active principle, in multi-microcapsule form | |
FI20002215A0 (fi) | Yhdistelmäpartikkelit | |
HUP0202311A2 (hu) | Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében | |
MY108564A (en) | Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
DK0799024T3 (da) | Farmaceutisk aerosol indeholdende mindst en sukker | |
AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
ATE347361T1 (de) | Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen | |
AU4260496A (en) | Propellant mixture for aerosol formulation | |
DE60104399D1 (de) | Pulverformulierung zur inhalation | |
RS20090083A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics | |
JO2430B1 (en) | Pharmaceutical formulas for dry powder inhalations in the form of solid pellets | |
SE0102276D0 (sv) | Device and method for the administration of a medicament | |
SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
CA2277365A1 (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | |
MXPA05009629A (es) | Composiciones que contienen trospio. | |
TNSN05048A1 (en) | Inhalation compositions with high drug ratios | |
MXPA02006518A (es) | Aerosol de gota liquida de gamma -ifn y metodo. | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
MXPA04010860A (es) | Composiciones terapeuticas de 1,2,3,6-tetrahidropirimidin-2-ona y metodos para usarla. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 10 (INCISO VIII) DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |